ANNEXON, INC. Other Current Liabilities
ANNEXON, INC. (ANNX) had Other Current Liabilities of $20.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2024-08-12
- 2024-06-30: Other Liabilities, Current $20.00K.
- 2024-03-31: Other Liabilities, Current $50.00K.
- 2023-12-31: Other Liabilities, Current $41.00K.
- 2023-09-30: Other Liabilities, Current $170.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2024-06-30 | $20.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $50.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $41.00K 10-Q · filed 2024-08-12 |
| 2023-09-30 | $170.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $161.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $384.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $180.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $170.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $164.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $189.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $139.00K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |